| July 2005 | ||||||
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
| 1 | 2 | |||||
| 3 | 4 | 5 | 6 | 7 | 8 | 9 |
| 10 | 11 | 12 | 13 | 14 | 15 | 16 |
| 17 | 18 | 19 | 20 | 21 | 22 | 23 |
| 24 | 25 | 26 | 27 | 28 | 29 | 30 |
| 31 | ||||||
| Jun Aug | ||||||
For more search options, please see the Advanced search form and the section of the User's Guide, Tips for Searching PULSE.
C H A N N E L S
• PULSE Home
Page
•
EXECUTIVE
EDITION
•
US News
•
Canada
News
•
UK News
•
New
Zealand News
•
Consumer
Advocacy
•
Health
Care Systems
•
Managed
Care/Medicaid
•
Co-occurring
Disorders
•
Clinical
studies
•
Pharmaceutical
News
•
Criminal
Justice Systems
•
Legislative
News
U S E R ' S G
U I D E
About
PULSE
PULSE Channels
Archives
Adding comments
Using the # link
Items that require registration
PULSE syndication
Tips for Searching PULSE
E M A I L S
U B S C R I P T I O N S
For WEEKLY summaries
of PULSE postings, see the weekly
email subscription form.
For DAILY mailings (powered
by Bloglet), please enter your e-mail address below:
PULSE ANNUAL No. 2
January 2003
Recent
Trends, Challenges and Issues in Funding Public Mental Health Services
in the US
March 2002
PULSE ANNUAL No. 1
October 2001
PULSE is powered by
Radio Userland.
© Bill Davis, 2000-2003.
![]()
New FDA-Approved Device Offers Hope to Depressed Patients Medical News Today story - "The Saint Louis University Health Sciences Center medical team involved in the research and development of an innovative therapy for depression - vagal nerve stimulation (VNS) - is starting a new clinic for patients who have treatment-resistant depression. The vagal nerve stimulator was approved Friday by the Food and Drug Administration for treatment-resistant depression following clinical trials around the United States, including Saint Louis University."
Quetiapine Seen Safe, Well Tolerated for Bipolar Depression Reuters Health story at Medscape - "Monotherapy with the atypical antipsychotic quetiapine is safe and effective for bipolar depression, according to a report in the July issue the American Journal of Psychiatry. ... 'In an unexpected post hoc analysis, quetiapine was found to be twice as effective as placebo in reducing suicidal thinking, and this improvement was evident as early as the first time point, the end of the first week, and at each and every time point thereafter,' Dr. Calabrese told Reuters Health. 'To my knowledge this is the first time any drug has been shown to have an ability to reduce suicidal thinking in a short-term study of bipolar depression.' " [Viewing Medscape resources requires registration, which is free].
Neuroscientists identify how trauma triggers long-lasting memories in the brain University of California - Irvine press release at EurekAlert - "A research team led by UC Irvine neuroscientists has identified how the brain processes and stores emotional experiences as long-term memories. The research, performed on rats, could help neuroscientists better understand why emotionally arousing events are remembered over longer periods than emotionally neutral events, and may ultimately find application in treatments for conditions such as post-traumatic stress disorder. The study shows that emotionally arousing events activate the brain's amygdala, the almond-shaped portion of the brain involved in emotional learning and memory, which then increases a protein called 'Arc' in the neurons in the hippocampus, a part of the brain involved in processing and enabling the storage of lasting memories. The researchers believe that Arc helps store these memories by strengthening the synapses, the connections between neurons. The study will appear in today's issue of the Proceedings of the National Academy of Sciences. "![]()